4.6 Article

Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)

Li Rong et al.

Summary: Non-alcoholic fatty liver disease (NAFLD), now renamed as metabolic (dysfunction) associated with fatty liver disease (MAFLD), is a series of diseases characterized by excessive lipid deposition in the liver and often accompanied by obesity, diabetes, dyslipidemia, abnormal blood pressure, and other metabolic disorders. While changes in diet and lifestyle are recognized as non-drug treatment strategies, current drug therapies mainly target the pathogenic factors, key links of pathogenesis, and related metabolic disorders of NAFLD. There is still a lack of specific drugs, but treatments based on the enterohepatic axis, targeting gut microbiota, and new metabolism-regulating drugs are emerging.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Biochemistry & Molecular Biology

Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis

Naihua Liu et al.

Summary: Excessive gluconeogenesis can lead to hyperglycemia and diabetes. Hepatic ZBTB22 expression is increased in diabetic patients and mice, and its overexpression enhances glucose output and lipid accumulation. ZBTB22 deficiency improves energy metabolism and reduces liver steatosis. Targeting hepatic ZBTB22/PEPCK1 may be a potential therapeutic approach for diabetes.

EMBO REPORTS (2023)

Article Multidisciplinary Sciences

Hepatic ZBTB22-mediated detoxification ameliorates acetaminophen-induced liver injury by inhibiting pregnane X receptor signaling

Yingjia Chen et al.

Summary: This study investigated the role of hepatic ZBTB22 in defense against APAP-induced acute liver injury (ALI). The expression of ZBTB22 was significantly reduced in ALI patients and mice. Deletion of ZBTB22 aggravated APAP overdose-induced ALI in mouse primary hepatocytes, while overexpression of ZBTB22 attenuated the pathological progression. Hepatocyte-specific ZBTB22 knockout also enhanced ALI.

ISCIENCE (2023)

Article Medicine, Research & Experimental

Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice

Kota Yano et al.

Summary: FGF21, an endocrine growth factor mainly secreted by the liver in response to a ketogenic diet and alcohol consumption, has pleiotropic metabolic effects including inducing hepatic fatty acid oxidation and ketogenesis. Continuous induction of FGF21-induced lipolysis by a high-fat diet may lead to liver damage, but hepatic fatty acid oxidation and ketone body synthesis can improve liver steatosis. Liver-derived ketone bodies may be utilized for energy in skeletal muscle, showing potential in treating nonalcoholic fatty liver disease.

LABORATORY INVESTIGATION (2022)

Article Endocrinology & Metabolism

CLSTN3 gene variant associates with obesity risk and contributes to dysfunction in white adipose tissue

Ningning Bai et al.

Summary: CLSTN3 gene is routinely expressed in human white adipose tissue (WAT), predominantly enriched in the adipocyte fraction. The variant rs7296261 in the CLSTN3 locus is associated with a high risk of obesity, and its risk allele is linked to an increase in CLSTN3 expression in human WAT. Overexpression of CLSTN3 in inguinal WAT of mice results in dysfunctional expansion, liver steatosis, and systemic metabolic deficiency.

MOLECULAR METABOLISM (2022)

Article Gastroenterology & Hepatology

Hepatic Kruppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance

Nannan Sun et al.

Summary: The transcription factor KLF16 plays a crucial role in hepatic lipid metabolism by regulating fatty acid oxidation and improving mitochondrial stress and oxidative stress, thus reducing hepatic steatosis and insulin resistance.
Article Biochemistry & Molecular Biology

Calsyntenin-3 interacts with the sodium-dependent vitamin C transporter-2 to regulate vitamin C uptake

Veedamali S. Subramanian et al.

Summary: The uptake of ascorbic acid in neurons is mediated by the sodium-dependent vitamin C transporter-2 (SVCT2) and regulated by the synaptogenic adhesion protein, calsyntenin-3 (CLSTN3). Decreased expression levels of SVCT2 and CLSTN3 have been observed in the hippocampus of Alzheimer's disease mouse models and patients, indicating a potential pathophysiological significance in neuronal cells.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Article Cell & Tissue Engineering

Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity

Hui-Lan Tan et al.

Summary: The study demonstrated that hAMSCs-CM significantly attenuated HFD-induced obesity in mice by inhibiting adipogenesis and lipogenesis, promoting energy expenditure, and reducing inflammation, suggesting a potential therapeutic approach for obesity and other metabolic disorders.

STEM CELL RESEARCH & THERAPY (2021)

Review Biochemistry & Molecular Biology

Current treatment paradigms and emerging therapies for NAFLD/NASH

Sana Raza et al.

Summary: NAFLD and NASH are significant diseases related to metabolic syndrome, with slow progress in the therapeutic field, urging the need to identify appropriate treatment methods.

FRONTIERS IN BIOSCIENCE-LANDMARK (2021)

Article Biochemistry & Molecular Biology

Neural regulation of energy and bone homeostasis by the synaptic adhesion molecule Calsyntenin-3

Sung-Jin Kim et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Agriculture, Multidisciplinary

Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1

Bo Cheng et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications

Jiezhong Chen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms

Cai-Yu Lian et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2020)

Article Biochemistry & Molecular Biology

trans-Chalcone inhibits high-fat diet-induced disturbances in FXR/SREBP-1c/FAS and FXR/Smad-3 pathways in the kidney of rats

Mohammad Reza Alipour et al.

JOURNAL OF FOOD BIOCHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

David Hojland Ipsen et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Review Gastroenterology & Hepatology

Triggering and resolution of inflammation in NASH

Susanne Schuster et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease

Chuan-Hao Lin et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)

Article Physiology

Triglyceride Metabolism in the Liver

Michele Alves-Bezerra et al.

COMPREHENSIVE PHYSIOLOGY (2018)

Review Biochemistry & Molecular Biology

The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Monica D. Chow et al.

MOLECULAR ASPECTS OF MEDICINE (2017)

Review Biochemistry & Molecular Biology

The role and regulation of the peroxisome proliferator activated receptor alpha in human liver

Sander Kersten et al.

BIOCHIMIE (2017)

Article Gastroenterology & Hepatology

Pathogenesis of Nonalcoholic Steatohepatitis

Mariana Verdelho Machado et al.

GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment

Hyunwoo Oh et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2016)

Review Gastroenterology & Hepatology

NAFLD: A multisystem disease

Christopher D. Byrne et al.

JOURNAL OF HEPATOLOGY (2015)

Review Medicine, Research & Experimental

Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies

Prasenjit Manna et al.

METABOLIC SYNDROME AND RELATED DISORDERS (2015)

Review Pharmacology & Pharmacy

Bile acid nuclear receptor FXR and digestive system diseases

Lili Ding et al.

ACTA PHARMACEUTICA SINICA B (2015)

Article Medicine, Research & Experimental

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

Changtao Jiang et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes

Andreas L. Birkenfeld et al.

HEPATOLOGY (2014)

Article Biochemistry & Molecular Biology

Calsyntenin-3 Molecular Architecture and Interaction with Neurexin 1α

Zhuoyang Lu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Review Gastroenterology & Hepatology

Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease

Jiao-Ya Xu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease

Sanja Stojsavljevic et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Endocrinology & Metabolism

Adipose tissue inflammation and ectopic lipid accumulation

Takayoshi Suganami et al.

ENDOCRINE JOURNAL (2012)

Editorial Material Oncology

The Human Protein Atlas - a tool for pathology

F. Ponten et al.

JOURNAL OF PATHOLOGY (2008)

Article Agriculture, Multidisciplinary

Ginsenoside Rc Modulates SIRT6-NRF2 Interaction to Alleviate Alcoholic Liver Disease

Zhisen Pan et al.

Summary: The study demonstrates that ginsenoside Rc attenuates hepatocyte damage and oxidative stress in alcoholic liver disease by up-regulating the SIRT6/NRF2 pathway, showing promising potential as a treatment for ALD.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY